Lanwei Xu

6.7k total citations · 2 hit papers
43 papers, 5.3k citations indexed

About

Lanwei Xu is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Lanwei Xu has authored 43 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 15 papers in Hematology and 10 papers in Immunology. Recurrent topics in Lanwei Xu's work include Developmental Biology and Gene Regulation (16 papers), Cancer-related gene regulation (11 papers) and Epigenetics and DNA Methylation (8 papers). Lanwei Xu is often cited by papers focused on Developmental Biology and Gene Regulation (16 papers), Cancer-related gene regulation (11 papers) and Epigenetics and DNA Methylation (8 papers). Lanwei Xu collaborates with scholars based in United States, Netherlands and Brazil. Lanwei Xu's co-authors include Warren S. Pear, Jon C. Aster, Fredrick G. Karnell, David Allman, Sonia Bakkour, Olga Shestova, Ivan Maillard, Avinash Bhandoola, Yiping He and Juli P. Miller and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Lanwei Xu

42 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Notch1 Expression in Early Lymphopoiesis Influences B versus T Lineage Determination

1999 766 citations David Allman, Lanwei Xu et al. Immunity profile →
Efficient and Rapid Induction of a Chronic Myelogenous Leukemia-Like Myeloproliferative Disease in Mice Receiving P210 bcr/abl-Transduced Bone Marrow

1998 627 citations Warren S. Pear, Juli P. Miller et al. Blood profile →

Peers

Countries citing papers authored by Lanwei Xu

Since Specialization

Citations

This map shows the geographic impact of Lanwei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanwei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanwei Xu more than expected).

Fields of papers citing papers by Lanwei Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanwei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanwei Xu. The network helps show where Lanwei Xu may publish in the future.

Co-authorship network of co-authors of Lanwei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lanwei Xu. A scholar is included among the top collaborators of Lanwei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanwei Xu. Lanwei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	miR-1343-3p, mediated by LncRNA ASMTL-AS1, induces ferroptosis in osteosarcoma progression by targeting TYRO3 2025 ·Gene ·Lanwei Xu, Songlin Yu, Dawei Li	0
2	The pseudokinase Trib1 regulates the transition of exhausted T cells to a KLR+ CD8+ effector state, and its deletion improves checkpoint blockade 2023 ·Cell Reports ·Susan McClory, (unknown), (unknown), Josephine R. Giles, Amy E. Baxter, Lanwei Xu, Phyllis A. Gimotty, Robert B. Faryabi, E. John Wherry, Warren S. Pear, Martha S. Jordan	4
3	Trib1 regulates eosinophil lineage commitment and identity by restraining the neutrophil program 2019 ·Blood ·(unknown), Sarah Stein, (unknown), Lanwei Xu, Gerald Wertheim, Rossana C. N. Melo, Warren S. Pear	24
4	MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia 2017 ·Science Signaling ·Kostandin V. Pajcini, Lanwei Xu, (unknown), Jelena Petrovic, Karol Palasiewicz, (unknown), Will Bailis, (unknown), Gerald Wertheim, Rajeswaran Mani, Natarajan Muthusamy, Yunlei Li, Jules P.P. Meijerink, Stephen C. Blacklow, Robert B. Faryabi, Sara Cherry, Warren S. Pear	15
5	Trib2 Suppresses Tumor Initiation in Notch-Driven T-ALL 2016 ·PLoS ONE ·Sarah Stein, (unknown), (unknown), Kostandin V. Pajcini, Takuya Ohtani, Lanwei Xu, Yunlei Li, Jules P.P. Meijerink, Robert B. Faryabi, Warren S. Pear	16
6	Modular domains within a super enhancer determine drug resistance in T-cell acute lymphoblastic leukemia 2016 ·Experimental Hematology ·Warren S. Pear, Yumi Yashiro–Ohtani, Jelena Petrovic, (unknown), (unknown), Lanwei Xu, Robert B. Faryabi, (unknown), Jon C. Aster, (unknown)	1
7	The Notch1 transcriptional activation domain is required for development and reveals a novel role for Notch1 signaling in fetal hematopoietic stem cells 2014 ·Genes & Development ·(unknown), Kostandin V. Pajcini, Teresa D’Altri, Lili Tu, Rajan Jain, Lanwei Xu, Michael Chen, Stacey Rentschler, Olga Shestova, Gerald Wertheim, John W. Tobias, Michael Kluk, Antony W. Wood, Jon C. Aster, Phyllis A. Gimotty, Jonathan A. Epstein, Nancy A. Speck, Anna Bigas, Warren S. Pear	47
8	Notch Ankyrin Repeat Domain Variation Influences Leukemogenesis and Myc Transactivation 2011 ·PLoS ONE ·Jon C. Aster, (unknown), Lanwei Xu, Fredrick G. Karnell, (unknown), Ivan Maillard, Gavin Histen, Yunsun Nam, Stephen C. Blacklow, Warren S. Pear	9
9	Pre-TCR signaling inactivates Notch1 transcription by antagonizing E2A 2009 ·Genes & Development ·Yumi Yashiro–Ohtani, Yiping He, Takuya Ohtani, Mary Elizabeth Jones, Olga Shestova, Lanwei Xu, Terry Fang, Mark Y. Chiang, Andrew M. Intlekofer, Stephen C. Blacklow, Yuan Zhuang, Warren S. Pear	144
10	Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras–initiated leukemia 2008 ·Journal of Clinical Investigation ·Mark Y. Chiang, Lanwei Xu, Olga Shestova, Gavin Histen, (unknown), Candice A. Romany, M. Eden Childs, Phyllis A. Gimotty, Jon C. Aster, Warren S. Pear	163
11	Tribbles homolog 2 inactivates C/EBPα and causes acute myelogenous leukemia 2006 ·Cancer Cell ·Karen Keeshan, Yiping He, Bas J. Wouters, Olga Shestova, Lanwei Xu, Hong Sai, Carlos G. Rodríguez, Ivan Maillard, John W. Tobias, Peter J.M. Valk, Martin Carroll, Jon C. Aster, Ruud Delwel, Warren S. Pear	195
12	The requirement for Notch signaling at the β-selection checkpoint in vivo is absolute and independent of the pre–T cell receptor 2006 ·The Journal of Experimental Medicine ·Ivan Maillard, Lili Tu, Arivazhagan Sambandam, Yumi Yashiro–Ohtani, John M. Millholland, Karen Keeshan, Olga Shestova, Lanwei Xu, Avinash Bhandoola, Warren S. Pear	162
13	Notch signaling controls the generation and differentiation of early T lineage progenitors 2005 ·Nature Immunology ·Arivazhagan Sambandam, Ivan Maillard, Valerie P. Zediak, Lanwei Xu, Rachel M. Gerstein, Jon C. Aster, Warren S. Pear, Avinash Bhandoola	289
14	Mastermind critically regulates Notch-mediated lymphoid cell fate decisions 2004 ·Blood ·Ivan Maillard, Andrew P. Weng, Andrea C. Carpenter, Carlos G. Rodríguez, Hong Sai, Lanwei Xu, David Allman, Jon C. Aster, Warren S. Pear	235
15	Notch Signaling Augments T Cell Responsiveness by Enhancing CD25 Expression 2003 ·The Journal of Immunology ·Scott Adler, Elise Chiffoleau, Lanwei Xu, (unknown), Jennifer M. Burg, Andrew D. Wells, Michael S. Wolfe, Laurence A. Turka, Warren S. Pear	180
16	The biology of chronic myelogenous leukemia:mouse models and cell adhesion 2002 ·Oncogene ·Jason A. Wertheim, Juli P. Miller, Lanwei Xu, Yiping He, Warren S. Pear	19
17	Deltex1 Redirects Lymphoid Progenitors to the B Cell Lineage by Antagonizing Notch1 2002 ·Immunity ·David J. Izon, Jon C. Aster, Yiping He, Andrew P. Weng, Fredrick G. Karnell, (unknown), Lanwei Xu, Sonia Bakkour, Carlos E. Rodríguez, David Allman, Warren S. Pear	211
18	Notch1 Regulates Maturation of CD4+ and CD8+ Thymocytes by Modulating TCR Signal Strength 2001 ·Immunity ·David J. Izon, Jennifer A. Punt, Lanwei Xu, Fredrick G. Karnell, David Allman, Peggy Myung, Nancy J. Boerth, (unknown), Gary A. Koretzky, Warren S. Pear	161
19	Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling 2000 ·Nature Medicine ·Barbara Varnum‐Finney, Lanwei Xu, Carolyn Brashem‐Stein, Cynthia Nourigat, David Flowers, Sonia Bakkour, Warren S. Pear, Irwin D. Bernstein	473
20	Dimerization of the testis brain RNA-binding protein (translin) is mediated through its C-terminus and is required for DNA- and RNA-binding 1998 ·Nucleic Acids Research ·Xin Wu, Lanwei Xu, Norman B. Hecht	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact